Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > News & Updates > Regulatory Updates > Drugs > Circular: Mecobalamin Manufacturing and Testing

Circular: Mecobalamin Manufacturing and Testing

Ijaz Mustafa Drugs, General April 5, 2022April 5, 2022

Mecobalamin-Manufacturing-Testing Download

Share this:

Twitter
Facebook

← Circular: Cefixime Capsule 200mg & 400mg Specifications.
DRAP issues guidelines on Good Pharmacovigilance Practices for Product Registration Holders →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem